Pfizer admits defeat on AstraZeneca bid

US pharmaceuticals giant Pfizer has called off its multi-billion pound bid to take over British-Swedish firm AstraZeneca. The decision came after AstraZeneca's board declined an offer worth almost £70bn.

View all 58 updates ›

AstraZeneca shareholder 'delighted by board's resolve'

ITV News Business Editor spoke to AstraZeneca shareholder and fund manager Neil Woodford this evening, who said he was "delighted by the resolve of the board" and happy with their decision to reject the takeover bid.

More on this story